Conghui Wang

Conghui Wang

Auto-generated profile, based on publicly available information

Conghui Wang

School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, 264005, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2020 in Nature
Verified
Journal Article
Closed access
PDF file
LBLinlin Bao
Linlin Bao
WDWei Deng
Wei Deng
BHBaoying Huang
Baoying Huang
HGHong Gao
Hong Gao
JLJiangning Liu
Jiangning Liu
CQChuan Qin
Chuan Qin

3 June 2020 in JAMA
Verified
Journal Article
Open access
PDF file
LLLing Li
Ling Li
WZWei Zhang
Wei Zhang
YHYu Hu
Yu Hu
XTXunliang Tong
Xunliang Tong
SZShangen Zheng
Shangen Zheng
ZLZhong Liu
Zhong Liu
Since December 2019, coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), has spread rapidly around the world, with high rates of transmission and substantial mortality. COVID-19 symptoms can range from mild, self-limited respiratory disease to severe progressive pneumonia, multiple organ failure, and even death.1,2 To date, there is no effective treatment or vaccine to contain the disease.

10 February 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZZZhuo Zhou
Zhuo Zhou
MCMengmeng Cao
Mengmeng Cao
YGYang Guo
Yang Guo
LZLili Zhao
Lili Zhao
JWJingfeng Wang
Jingfeng Wang
TDTao Deng
Tao Deng
The ribonucleoprotein (RNP) of the influenza A virus is responsible for the transcription and replication of viral RNA in the nucleus. These processes require interplay between host factors and RNP components. Here, we report that the Fragile X mental retardation protein (FMRP) targets influenza virus RNA synthesis machinery and facilitates virus replication both in cell culture and in mice. We demonstrate that FMRP transiently associates with viral RNP and stimulates viral RNP assembly through RNA-mediated interaction with the nucleoprotein. Furthermore, the KH2 domain of FMRP mediates its association with the nucleoprotein. A point mutation (I304N) in the KH2 domain, identified from a Fragile X syndrome patient, disrupts the FMRP–nucleoprotein association and abolishes the ability of FMRP to participate in viral RNP assembly. We conclude that FMRP is a critical host factor used by influenza viruses to facilitate viral RNP assembly. Our observation reveals a mechanism of influenza virus RNA synthesis and provides insights into FMRP functions.

1 September 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GYGangqiang Yang
Gangqiang Yang
MGMeng Gao
Meng Gao
YSYixiao Sun
Yixiao Sun
CWConghui Wang
Conghui Wang
XFXiaojuan Fang
Xiaojuan Fang
HYHui Yu
Hui Yu

1 January 2017 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
CWConghui Wang
Conghui Wang
YZYanjing Zhang
Yanjing Zhang
LHLianLian Han
LianLian Han
LGLi Guo
Li Guo
HZHui Zhong
Hui Zhong
JWJianwei Wang
Jianwei Wang